Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Grisol 1% spray
1310020Q0BBABAB
|
Grisol | Griseofulvin | Skin | No data available |
|
Grisol AF 1% spray
1310020Q0BBAAAB
|
Grisol | Griseofulvin | Skin | No data available |
|
Grisovin 125mg tablets
0502050B0BCAAAB
|
Grisovin | Griseofulvin | Infections | No data available |
|
Grisovin 500mg tablets
0502050B0BCABAC
|
Grisovin | Griseofulvin | Infections | No data available |
|
Ground Ivy herb tincture
190606000BCWRA0
|
Proprietary compound preparation BNF 1906060 | Other tincture preparations | Other Drugs and Preparations | No data available |
|
Guaiacol 75mg/5ml / Codeine 7mg/5ml oral solution
0309020ACAAAAAA
|
Guaiacol/codeine | Guaiacol and codeine | Respiratory System | No data available |
|
Guaifenesin 100mg/5ml / Levomenthol 1.1mg/5ml soln 5ml sach
0309020G0AAAMAM
|
Guaifenesin (Expectorant/Demulcents) | Guaifenesin | Respiratory System | No data available |
|
Guaifenesin 100mg/Cetylpyridinium chloride 2.5mg/5ml soln SF
0309020G0AAAKAK
|
Guaifenesin (Expectorant/Demulcents) | Guaifenesin | Respiratory System | No data available |
|
Guaifenesin 33.33mg/5ml oral solution sugar free
0309020G0AAAJAJ
|
Guaifenesin (Expectorant/Demulcents) | Guaifenesin | Respiratory System | No data available |
|
Guaifenesin 50mg/5ml / Pseudoephedrine 10mg/5ml soln SF
0309020G0AAASAS
|
Guaifenesin (Expectorant/Demulcents) | Guaifenesin | Respiratory System | No data available |
|
Guaifenesin 50mg/Cetylpyridinium chloride 2.5mg/5ml soln SF
0309020G0AAAHAH
|
Guaifenesin (Expectorant/Demulcents) | Guaifenesin | Respiratory System | No data available |
|
Guaifenesin 66.67mg/5ml / Pseudoephedrine 20mg/5ml soln SF
0309020G0AAAQAQ
|
Guaifenesin (Expectorant/Demulcents) | Guaifenesin | Respiratory System | No data available |
|
Guaifenesin 66.67mg/5ml oral solution
0309020G0AAARAR
|
Guaifenesin (Expectorant/Demulcents) | Guaifenesin | Respiratory System | No data available |
|
Guaifenesin powder
0309020G0AAAAAA
|
Guaifenesin (Expectorant/Demulcents) | Guaifenesin | Respiratory System | No data available |
|
Guanethidine 1% / Adrenaline 0.2% eye drops
1106000S0AAAEAE
|
Guaneth monosulfate (Eye) | Guanethidine monosulfate | Eye | No data available |
|
Guanethidine 10mg/1ml solution for injection ampoules
0205030N0AAAAAA
|
Guaneth monosulfate (Systemic) | Guanethidine monosulfate | Cardiovascular System | No data available |
|
Guanethidine 3% / Adrenaline 0.5% eye drops
1106000S0AAAFAF
|
Guaneth monosulfate (Eye) | Guanethidine monosulfate | Eye | No data available |
|
Guanfacine 2mg tablets
0205020G0AAADAD
|
Guanfacine hydrochloride | Guanfacine hydrochloride | Cardiovascular System | No data available |
|
Guanfacine 5mg modified-release tablets
0404000V0AAAEAE
|
Guanfacine | Guanfacine | Central Nervous System | No data available |
|
Guanfacine 6mg modified-release tablets
0404000V0AAAFAF
|
Guanfacine | Guanfacine | Central Nervous System | No data available |
|
Guanfacine 7mg modified-release tablets
0404000V0AAAGAG
|
Guanfacine | Guanfacine | Central Nervous System | No data available |
|
Guar gum 5g granules sachets sugar free
0601023I0AAADAD
|
Guar gum | Guar gum | Endocrine System | No data available |
|
Guardium acid reflux control 20mg gastro-resistant tablets
0103050E0BEAAAA
|
Guardium | Esomeprazole | Gastro-Intestinal System | No data available |
|
Guarem 5g granules sachets
0601023I0BCAAAD
|
Guarem | Guar gum | Endocrine System | No data available |
|
Guselkumab 100mg/1ml inj pre-filled disposable devices
1305030F0AAABAB
|
Guselkumab | Guselkumab | Skin | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.